Similar articles

• Fibrinogen derivatives. A laboratory and clinical study.

  Vermylen J. Vermylen J. Verh K Vlaam Acad Geneeskd Belg. 1972;34(2):125-208. Verh K Vlaam Acad Geneeskd Belg. 1972. PMID: 4278099 Review. No abstract available.
• The clinical significance of fibrinogen degradation products.

  Bick RL. Bick RL. Semin Thromb Hemost. 1982 Oct;8(4):302-30. doi: 10.1055/s-2007-1005060. Semin Thromb Hemost. 1982. PMID: 6758120 Review. No abstract available.
• [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].

  Wenzel E, Holzhüter H, Muschietti F, Angelkort B, Ochs HG, Pusztai-Markos S, Nowak H, Stürner H. Wenzel E, et al. Dtsch Med Wochenschr. 1974 Apr 12;99(15):746-56. doi: 10.1055/s-0028-1107838. Dtsch Med Wochenschr. 1974. PMID: 4858105 German. No abstract available.
• Elimination of iodine-labelled fibrinogen in intravascular coagulation and in the normal state. Experimental and clinical studies.

  Zetterqvist E. Zetterqvist E. Acta Physiol Scand Suppl. 1969;325:1-41. Acta Physiol Scand Suppl. 1969. PMID: 4900570 Review. No abstract available.
• Fibrinogen-fibrin-related antigen pattern in human blood. Differences between plasma and serum from pateints with disseminated intravascular coagulation.

  Jacobsen CD, Hoak JC, Wu KK, Fry GL. Jacobsen CD, et al. Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):266-76. Thromb Diath Haemorrh. 1974. PMID: 4217475 No abstract available.